News Website

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.

Read Full Article

Pearsanta to begin study of endometriosis test with IRB approval - Medical Device Network

Pearsanta to begin study of endometriosis test with IRB approval Medical Device Network

Published: April 17, 2025, 10:54 a.m.

Read Full Article

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer - Physician's Weekly

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer Physician's Weekly

Published: April 17, 2025, 10:41 a.m.

Read Full Article

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Quantisnow

Published: April 16, 2025, 12:15 p.m.

Read Full Article

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Bluefield Daily Telegraph

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Bluefield Daily Telegraph

Published: April 16, 2025, 12:14 p.m.

Read Full Article

Jalen Rose supports wife Molly Qerim after LaVar Ball's inappropriate comment on ESPN - Yahoo Sports

Jalen Rose supports wife Molly Qerim after LaVar Ball's inappropriate comment on ESPN Yahoo Sports

Published: April 16, 2025, 9:17 a.m.

Read Full Article

Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets - Frontiers

Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets Frontiers

Published: April 15, 2025, 3:08 p.m.

Read Full Article

The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma - Frontiers

The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma Frontiers

Published: April 15, 2025, 2:55 p.m.

Read Full Article

Is your home messing with your health? - 15 Apr 2025 - New! Magazine - Readly | All magazines - one magazine app subscription

Is your home messing with your health? - 15 Apr 2025 - New! Magazine Readly | All magazines - one magazine app subscription

Published: April 15, 2025, 8:23 a.m.

Read Full Article

Latest Articles

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Pearsanta to begin study of endometriosis test with IRB approval - Medical Device Network

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer - Physician's Weekly

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Bluefield Daily Telegraph

Jalen Rose supports wife Molly Qerim after LaVar Ball's inappropriate comment on ESPN - Yahoo Sports

Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets - Frontiers

The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma - Frontiers

Is your home messing with your health? - 15 Apr 2025 - New! Magazine - Readly | All magazines - one magazine app subscription

Subscribe to Our Newsletter